Global Ultomiris Drug Market Size, Share, and COVID-19 Impact Analysis, By Indication (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End Use (Adult and Pediatric), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.
$5550
Total
$5550
Need assistance?
Call us or write to us:
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies